NASDAQ:NGM   NGM Biopharmaceuticals, Inc
TECHNICAL ANALYSIS
Price bouncing off a strong support zone after a 44% drop and showing lateralization in the zone. Company in a very profitable industry, resistant to crises and in the past with strong movements.
A negative FREE CASH FLOW. The value of the total assets is higher than the debt, many possibilities to recover its price before the fall,


Precio rebotando en una fuerte zona de soporte después de una caída de 44% y mostrando lateralización en la zona. Empresa en una industria muy rentable, resistente a crisis y en el pasado con movimientos fuertes.
Un FREE CASH FLOW negativo. El valor de los activos totales es superior a la deuda, muchas posibilidades de recuperar su precio antes de la caída,


FEAR & GREED INDEX : 36 -Fear,,
“sea temerosos cuando otros son codiciosos, y sólo codicioso cuando otros son temerosos”
“be fearful when others are greedy, and only greedy when others are fearful” - Warren Buffett


PRICE TARGET: $22 ( Raymond James)


HEDGE FUND TRACK:
AQUILO CAPITAL MANAGEMENT, LLC //// % of Portafolio 5.91% //// # of shares 1,124,237
BAKER BROS. ADVISORS LP //// % of Portafolio 0.04 % //// # of shares 291,801
COLUMN GROUP LLC //// % of Portafolio 42.88 % //// # of shares 15,396,116
Merck & COMPANY ., Inc. //// % of Portafolio 6.8 % //// # of shares 12,955,026


Important note: ⚠️ All trades have risks that the investor must consider before investing. VivirdelTrading.club makes a disclaimer of any operation that may generate losses. All information transmitted by the channel, the page and the alert system is shared in good faith. There is no guarantee of 100% of the executed operations, as these are based on statistical models and assumptions regarding the past behavior of the price of a share, but they do not guarantee the same future behavior.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.